The Valley Desk

ArticleAlimentary pharmacology & therapeuticsPublished

Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Alimentary pharmacology & therapeutics
Published
Subject terms
Humans; Inflammatory Bowel Diseases; C-Reactive Protein; Gastrointestinal Agents; Blood Sedimentation; Treatment Outcome; Remission Induction; Bayes Theorem; Prospective Studies; Dose-Response Relationship, Drug; Adolescent; Child
PubMed ID
39812549
PubMed Central ID
PMC11869157
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal